Interactome analysis of gene expression profiles of cervical cancer reveals dysregulated mitotic gene clusters

American Journal of Translational Research

Volumn 9, Issue 6, 2017, Pages 3048-3059

  Cheng, Jing ^a   Lu, Xiaosheng ^a   Wang, Jianguang ^b   Zhang, Huina ^a   Duan, Ping ^a   Li, Chunyang ^b  

^a THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Cervical cancer; Computational analysis; DNA replication; Mitosis

Indexed keywords

CYCLIN A2; CYCLIN B2; CYCLIN DEPENDENT KINASE 1; DNA POLYMERASE; MINICHROMOSOME MAINTENANCE PROTEIN; MINICHROMOSOME MAINTENANCE PROTEIN 10; MINICHROMOSOME MAINTENANCE PROTEIN 2; MINICHROMOSOME MAINTENANCE PROTEIN 4; MINICHROMOSOME MAINTENANCE PROTEIN 5; MINICHROMOSOME MAINTENANCE PROTEIN 6; MOLECULAR MOTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DP2; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CELL CYCLE CHECKPOINT; CELL CYCLE PROGRESSION; CELL DIVISION; CONTROLLED STUDY; DNA REPLICATION; FEMALE; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE ONTOLOGY; GENE REGULATORY NETWORK; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; MITOSIS; MUSCLE CONTRACTION; MUSCLE DEVELOPMENT; MUSCLE FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER;

EID: 85021307599     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87-108.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-350.
4. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ and Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527.
5. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H and de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010; 401: 70-79.
6. Kjaer SK, Frederiksen K, Munk C and Iftner T. Long-term absolute risk of cervical intraepithe-lial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst 2010; 102: 1478-1488.
7. Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, Bratti MC, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Wright TC, Solomon D, Chen Z, Schussler J, Castle PE and Burk RD. The carci-nogenicity of human papillomavirus types reflects viral evolution. Virology 2005; 337: 76-84.
8. Moody CA and Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010; 10: 550-560.
9. Dyson N, Howley PM, Munger K and Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934-937.
10. Demers GW, Halbert CL and Galloway DA. Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Virology 1994; 198: 169-174.
11. Gage JR, Meyers C and Wettstein FO. The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties. J Virol 1990; 64: 723-730.
12. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E and Howley PM. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 1989; 8: 4099-4105.
13. Jones DL, Alani RM and Munger K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-me-diated inhibition of cdk2. Genes Dev 1997; 11: 2101-2111.
14. Zerfass-Thome K, Zwerschke W, Mannhardt B, Tindle R, Botz JW and Jansen-Durr P. Inactiva-tion of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 1996; 13: 2323-2330.
15. Huibregtse JM, Scheffner M and Howley PM. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 1991; 10: 4129-4135.
16. Lechner MS and Laimins LA. Inhibition of p53 DNA binding by human papillomavirus E6 proteins. J Virol 1994; 68: 4262-4273.
17. Howie HL, Katzenellenbogen RA and Galloway DA. Papillomavirus E6 proteins. Virology 2009; 384: 324-334.
18. DiMaio D and Mattoon D. Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene 2001; 20: 7866-7873.
19. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W and Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015; 43: e47.
20. Gene Ontology Consortium. The Gene Ontology (GO) project in 2006. Nucleic Acids Res 2006; 34: D322-326.
21. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC and Lempicki RA. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003; 4: P3.
22. Kanehisa M and Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28: 27-30.
23. Szklarczyk D, Franceschini A, Kuhn M, Simo-novic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, Jensen LJ and von Mering C. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 2011; 39: D561-568.
24. Jones C. Cervical cancer: is herpes simplex virus type II a cofactor? Clin Microbiol Rev 1995; 8: 549-556.
25. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
26. Zelmanowicz A and Hildesheim A. Family history of cancer as a risk factor for cervical carcinoma: a review of the literature. Papillomavirus Report 2004; 15: 113-120.
27. Reshmi G, Surya R, Jissa VT, Babu PS, Preethi NR, Santhi WS, Jayaprakash PG and Pillai MR. C-T variant in a miRNA target site of BCL2 is associated with increased risk of human papilloma virus related cervical cancer--an in silico approach. Genomics 2011; 98: 189-193.
28. Wu HH, Liu YF, Yang SF, Lin WL, Chen SC, Han CP, Wang HL, Lin LY and Wang PH. Association of single-nucleotide polymorphisms of high-mobility group box 1 with susceptibility and clinicopathological characteristics of uterine cervical neoplasia in Taiwanese women. Tumour Biol 2016; [Epub ahead of print].
29. Sousa H, Oliveira S, Santos AM, Catarino R, Moutinho J and Medeiros R. Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to inva- sive cervical cancer. Tumour Biol 2014; 35: 2561-2564.
30. Ojesina AI, Lichtenstein L, Freeman SS, Peda-mallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio L, Cibulskis K, Bertelsen B, Romero-Cordoba S, Trevino V, Vazquez-Santillan K, Guadarrama AS, Wright AA, Rosenberg MW, Duke F, Kaplan B, Wang R, Nickerson E, Walline HM, Lawrence MS, Stewart C, Carter SL, McKenna A, Rodriguez-Sanchez IP, Espinosa-Castilla M, Woie K, Bjorge L, Wik E, Halle MK, Hoivik EA, Krakstad C, Gabino NB, Gomez-Macias GS, Valdez-Chapa LD, Garza-Rodriguez ML, Maytorena G, Vazquez J, Rodea C, Cravioto A, Cortes ML, Greulich H, Crum CP, Neuberg DS, Hidalgo-Miranda A, Escareno CR, Akslen LA, Carey TE, Vintermyr OK, Gabriel SB, Barrera-Saldana HA, Melendez-Zajgla J, Getz G, Sal-vesen HB and Meyerson M. Landscape of genomic alterations in cervical carcinomas. Nature 2014; 506: 371-375.
31. Peng G, Dan W, Jun W, Junjun Y, Tong R, Baoli Z and Yang X. Transcriptome profiling of the cancer and adjacent nontumor tissues from cervical squamous cell carcinoma patients by RNA sequencing. Tumour Biol 2015; 36: 3309-3317.
32. Safari A, Seifoleslami M, Yahaghi E, Sedaghati F and Khameneie MK. Upregulation of miR-20a and miR-10a expression levels act as potential biomarkers of aggressive progression and poor prognosis in cervical cancer. Tumour Biol 2015; [Epub ahead of print].
33. Jing L, Yuan W, Ruofan D, Jinjin Y and Haifeng Q. HOTAIR enhanced aggressive biological behaviors and induced radio-resistance via inhibiting p21 in cervical cancer. Tumour Biol 2015; 36: 3611-3619.
34. Reshmi G, Chandra SS, Babu VJ, Babu PS, Santhi WS, Ramachandran S, Lakshmi S, Nair AS and Pillai MR. Identification and analysis of novel microRNAs from fragile sites of human cervical cancer: computational and experimental approach. Genomics 2011; 97: 333-340.
35. Punt S, Corver WE, van der Zeeuw SA, Kielbasa SM, Osse EM, Buermans HP, de Kroon CD, Jor-danova ES and Gorter A. Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival. Oncotarget 2015; 6: 38681-38694.
36. Motta PM. Ultrastructure of smooth muscle. Boston: Kluwer Academic Publishers; 1990.
37. Henneke G, Koundrioukoff S and Hubscher U. Multiple roles for kinases in DNA replication. EMBO Rep 2003; 4: 252-256.
38. Enserink JM and Kolodner RD. An overview of Cdk1-controlled targets and processes. Cell Div 2010; 5: 11.
39. Nigg EA. Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2001; 2: 21-32.
40. van Dam PA, van Dam PJ, Rolfo C, Giallombar-do M, van Berckelaer C, Trinh XB, Altintas S, Huizing M, Papadimitriou K, Tjalma WA and van Laere S. In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment. Oncotarget 2016; 7: 2780-2795.
41. Schlecht NF, Burk RD, Adrien L, Dunne A, Kawachi N, Sarta C, Chen Q, Brandwein-Gensler M, Prystowsky MB, Childs G, Smith RV and Belbin TJ. Gene expression profiles in HPV-infected head and neck cancer. J Pathol 2007; 213: 283-293.
42. Evrin C, Clarke P, Zech J, Lurz R, Sun J, Uhle S, Li H, Stillman B and Speck C. A double-hexa-meric MCM2-7 complex is loaded onto origin DNA during licensing of eukaryotic DNA replication. Proc Natl Acad Sci U S A 2009; 106: 20240-20245.
43. Thu YM and Bielinsky AK. Enigmatic roles of Mcm10 in DNA replication. Trends Biochem Sci 2013; 38: 184-194.